A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
NextPoint Therapeutics, Inc.
NextPoint Therapeutics, Inc.
BioEclipse Therapeutics
Celgene
Novartis
Valerio Therapeutics
Valerio Therapeutics
INSYS Therapeutics Inc
Alaunos Therapeutics